Physiologically Based Pharmacokinetic Modeling of Arsenic in the Mouse

REFERENCES

• Baker , H. , Lindsey , J. and Weisbroth , S. 1979 . The laboratory rat: Volume I—Biology and diseases. , San Diego, CA : Academic Press .
   Google Scholar
• Bernstam , L. and Nriagu , J. 2000 . Molecular aspects of arsenic stress . J. Toxicol. Environ. Health B , 3 : 293 – 322 .
   PubMed Web of Science ®Google Scholar
• Brown , R. , Delp , M. , Lindstedt , S. , Rhomberg , L. and Beliles , R. 1997 . Physiological parameter values for physiologically based pharmacokinetic models . Toxicol Ind. Health , 13 : 407 – 484 .
   PubMed Web of Science ®Google Scholar
• Chen , C. and Lin , L. 1994 . “ Human carcinogenicity and atherogenicity induced by chronic exposure to inorganic arsenic ” . In Arsenic in the environment. Part II: Human health and ecosystem effects , Edited by: Nriagu , J. O. 109 – 131 . New York : John Wiley & Sons .
   Google Scholar
• Clewell , H. , Barton , H. , Gentry , P. , Shipp , A. , Yager , J. and Andersen , M. 1998 . Requirements for a biologically realistic arsenic risk assessment . Int. J. Toxicol. , 18 : 131 – 147 .
   Web of Science ®Google Scholar
• DelRazo , L. , Styblo , M. and Thomas , D. 2000 . “ Determination of trivalent methylated arsenic species in water, cultured rat hepatocytes, and human urine ” . In Fourth International Conference on Arsenic Exposure and Health Effects Poster 10
   Google Scholar
• Easterling , M. , Stylbo , M. , Evans , M. and Kenyon , E. 2002 . Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes: Mechanistic insights and implications for further experiments . J. Phar-macokinet. Pharmacodyn. , 29 : 207 – 233 .
   PubMed Web of Science ®Google Scholar
• Golub , M. S. , Macintosh , M. S. and Baumrind , N. 1998 . Developmental and reproductive toxicity ofinorganic arsenic: Animal studies and human concerns . J. Toxicol. Environ. Health B , 1 : 199 – 241 .
   PubMed Web of Science ®Google Scholar
• Hall , L. , George , S. , Kohan , M. , Stylbo , M. and Thomas , D. 1997 . In vitro methylation of inorganic arsenic on mouse intestinal cecum . Toxicol. Appl. Pharmacol. , 148 : 101 – 109 .
   Google Scholar
• Healy , S. , Casarez , E. , Ayala-Fierro , F. and Aposhian , H. 1998 . Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice . Toxicol. Appl. Pharmacol. , 148 : 65 – 70 .
   PubMed Web of Science ®Google Scholar
• Hsueh , Y.-M. , Huang , Y.-L. , Huang , C.-C. , Wu , W.-L. , Chen , H.-M. , Yang , M.-H. , Lue , L.-C. and Chen , C.-J. 1998 . Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasishyperendemic area in Taiwan . J. Toxicol. Environ. Health A , 54 : 431 – 444 .
   PubMed Web of Science ®Google Scholar
• Hughes , M. and Kenyon , E. 1998 . Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsenic acid in the mouse after intravenous administration . J. Toxicol. Environ. Health A , 53 : 95 – 112 .
   PubMed Web of Science ®Google Scholar
• Hughes , M. , Kenyon , E. , Edwards , B. , Mitchell , C. and Thomas , D. 1999 . Strain-dependent disposition of inorganic arsenic in the mouse . Toxicology , 137 : 95 – 108 .
   PubMed Web of Science ®Google Scholar
• Hughes , M. , Menache , M. and Thompson , D. 1994 . Dose-dependent disposition of sodium arsenate in mice following acute oral exposure . Fundam. Appl. Toxicol. , 22 : 80 – 89 .
   PubMedGoogle Scholar
• Kanisawa , M. and Schroeder , H. 1967 . Life term studies on the effects of arsenic, germanium, tin, and vanadium on spontaneous tumors in mice . Cancer Res. , 27 : 1192 – 1195 .
   PubMed Web of Science ®Google Scholar
• Kenyon , E. , Fea , M. , Styblo , M. and Evans , M. 2001 . Application of modelling techniques to the planning of in vitro arsenic kinetic studies . ATLA , 29 : 15 – 33 .
   Google Scholar
• Kenyon , E. , Hughes , M. and Levander , O. 1997 . Influence of dietary selenium on the disposition of arsenate in the female B6C3F1 mouse . J. Toxicol. Eviron. Health , 51 : 279 – 299 .
   PubMed Web of Science ®Google Scholar
• King , F. , Dedrick , R. , Collins , J. , Matthews , H. and Birnbaum , L. 1983 . Physiological model for the pharmacokinetics of 2,3,7,8-tetrachlorodibenzofuran in several species . Toxicol. Appl. Pharmacol. , 67 : 392 – 400 .
   Web of Science ®Google Scholar
• Kitchin , K. 2001 . Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites . Toxicol. Appl. Pharmacol. , 172 : 249 – 261 .
   PubMed Web of Science ®Google Scholar
• Le , X. , Lu , X. , Ma , M. , Cullen , W. , Aposhian , H. and Zheng , B. 2000 . Speciation of key arsenic metabolic intermediates in human urine . Anal. Chem. , 72 : 5172 – 5177 .
   PubMed Web of Science ®Google Scholar
• Lubin , J. , Pottern , L. , Stone , B. and Fraumeni , J. 2000 . Respiratory cancer in a cohort of copper smelter workers: Results from more than 50 years of follow-up . Am. J. Epidemiol. , 151 : 554 – 565 .
   PubMed Web of Science ®Google Scholar
• Mann , S. , Droz , P. and Vahter , M. 1996a . A physiologically based pharmacokinetic model for arsenic exposure: I. Development in hamsters and rabbits . Toxicol. Appl. Pharmacol. , 136 : 8 – 22 .
   PubMedGoogle Scholar
• Mann , S. , Droz , P. and Vahter , M. 1996b . A physiologically based pharmaokinetic model for arsenic exposure: II. Validation and application in humans . Toxicol. Appl. Pharmacol. , 140 : 471 – 486 .
   PubMed Web of Science ®Google Scholar
• Mass , M. 1998 . Wild type and p53 deficient mice exposed to arsenical compounds EPA Study Number 97–05
   Google Scholar
• Moser , G. , Goldsworthy , T. and Tice , R. 2000 . Sodium arsenite studies in p53 +/− Mice. , Denver, CO : AWWA Research Foundation and the American Water Works Association .
   Google Scholar
• Ng , J. , Seawright , S. , Wi , L. , Garnett , C. , Cirswell , B. and Moore , M. 1999 . “ Tumours in mice induced by exposure to sodium arsenate in drinking water ” . In Arsenic exposure and health effects , Edited by: Chappell , W. , Abernathy , C. and Calderon , R. 217 – 223 . Elsevier .
   Google Scholar
• Sampayo-Reyes , A. , Zakharyan , R. , Healy , S. and Aposhian , H. 2000 . Monomethylarsonic acid reductase and monomethyarsonous acid in hamster tissue . Chem. Res. Toxicol. , 13 : 1181 – 1186 .
   PubMed Web of Science ®Google Scholar
• Tsai , S.-M. , Wang , T.-N. and Ko , Y.-C. 1998 . Cancer mortality trends in a Blackfoot disease endemic community of Taiwan following water source replacement . J. Toxicol. Environ. Health A , 55 : 389 – 404 .
   PubMed Web of Science ®Google Scholar
• Vega , L. , Styblo , M. , Patterson , R. , Cullen , W. , Wang , C. and Germolec , D. 2001 . Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes . Toxicol. Appl. Pharmacol. , 172 : 225 – 232 .
   PubMed Web of Science ®Google Scholar
• Waalkes , M. , Keefer , L. and Diwan , B. 2000 . Induction of proliferative lesions of the uterus, testes, and liver in Swiss mice given repeated injections of sodium arsenate: Possible estrogenic mode of action . Toxi-col. Appl. Pharmacol. , 166 : 24 – 35 .
   PubMed Web of Science ®Google Scholar
• Wang , Z. , Dey , S. , Rosen , B. and Rossman , T. 1996 . Efflux-mediated resistance to arsenicals in arsenic-resistant and -hypersensitive Chinese hamster cells . Toxicol. Appl. Pharmacol. , 137 : 112 – 119 .
   PubMed Web of Science ®Google Scholar
• Yu , D. 1999 . A pharmacokinetic modeling of inorganic arsenic: A short-term oral exposure model for humans . Chemosphere. , 39 : 2737 – 2747 .
   PubMed Web of Science ®Google Scholar
• Yu , R. , Hsu , K. , Chen , C. and Froines , J. 2000 . Arsenic methylation capacity and skin cancer . Cancer Epide-miol. Biomarkers , 9 : 1259 – 1262 .
   PubMed Web of Science ®Google Scholar
• Zakharyan , R. , Wu , Y. , Bogdan , G. and Aposhian , H. 1995 . Enzymatic methylation of arsenic compounds: Assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver . Chem. Res. Toxicol. , 8 : 1029 – 1038 .
   PubMed Web of Science ®Google Scholar